US Patent Office rescinds controversial prosecution rules
This article was originally published in Scrip
Executive Summary
The US Patent and Trademark Office has announced that it has rescinded "highly controversial" rule changes, dealing with the prosecution of patents that became the subject of a fierce debate and prompted a lawsuit by GlaxoSmithKline.